F.C. Bombaldi de Souza, E.D. Mariano, D. N. da Rocha, K. Menezes, T.C. Lopes de Castro, R. V. Capelletti, Y. M. Berto, F. G. Duarte, W. Jeveaux, R.D. Fanganiello, J. M. Ferreira
{"title":"从自体细胞库到异体细胞疗法生产:为生产符合 GMP 标准的基于 MSC 的疗法制定 CMC 战略","authors":"F.C. Bombaldi de Souza, E.D. Mariano, D. N. da Rocha, K. Menezes, T.C. Lopes de Castro, R. V. Capelletti, Y. M. Berto, F. G. Duarte, W. Jeveaux, R.D. Fanganiello, J. M. Ferreira","doi":"10.1016/j.jcyt.2024.03.246","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505215,"journal":{"name":"Cytotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FROM AUTOLOGOUS CELL BANKING TO ALLOGENEIC CELL THERAPY MANUFACTURING: DEVELOPING A CMC STRATEGY FOR THE PRODUCTION OF A GMP-COMPLIANT MSC-BASED THERAPY\",\"authors\":\"F.C. Bombaldi de Souza, E.D. Mariano, D. N. da Rocha, K. Menezes, T.C. Lopes de Castro, R. V. Capelletti, Y. M. Berto, F. G. Duarte, W. Jeveaux, R.D. Fanganiello, J. M. Ferreira\",\"doi\":\"10.1016/j.jcyt.2024.03.246\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505215,\"journal\":{\"name\":\"Cytotherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cytotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcyt.2024.03.246\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcyt.2024.03.246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
FROM AUTOLOGOUS CELL BANKING TO ALLOGENEIC CELL THERAPY MANUFACTURING: DEVELOPING A CMC STRATEGY FOR THE PRODUCTION OF A GMP-COMPLIANT MSC-BASED THERAPY